Neuropeptide Y (NPY) receptors are involved in different types of biological processes. It is a class of G-Protein coupled receptors sensitive to closely associated peptide hormones such as peptide YY, pancreatic polypeptide, and neuropeptide Y. NPY is closely related to central mechanism involving obesity and food intake; however the topic is still a part of extensive medical research.
Increase in prevalence of various diseases related to obesity and surge in overweight populace drives the market.
Moreover, unhealthy urban lifestyle and increase in number of fast food eating populace susceptible to sudden weight gain, is expected to boost the market growth.
However, number of limited manufacturers and distribution channels is anticipated to impede the market growth.
The global Neuropeptide Y Receptor market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Neuropeptide Y Receptor market based on company, product type, end user and key regions.
This report studies the global market size of Neuropeptide Y Receptor in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Neuropeptide Y Receptor in these regions.
This research report categorizes the global Neuropeptide Y Receptor market by top players/brands, region, type and end user. This report also studies the global Neuropeptide Y Receptor market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck & Co
Market size by Product
Market size by End User
Market size by Region
Central & South America
Rest of Central & South America
Middle East & Africa
The study objectives of this report are:
To study and analyze the global Neuropeptide Y Receptor market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To understand the structure of Neuropeptide Y Receptor market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Neuropeptide Y Receptor companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Neuropeptide Y Receptor submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Neuropeptide Y Receptor are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Neuropeptide Y Receptor market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.